Rapid acceleration of the lower arm correlates with agonist EMGs during the initial phase

Fifty-eight healthy subjects made rapid elbow extensions to a target over 54 degrees. Angular acceleration was measured and surface electromyograms (EMGs) were recorded from the antagonistic muscles using monopolar rather than bipolar electrode configurations. Marked individual differences were found in the peak value of the first derivative of acceleration (dAcc/dt_Pk). The dAcc/dt_Pk correlated with both quantitative and qualitative properties of the agonist EMGs, but not with those of the antagonist EMG. The agonist EMGs, integrated until the moment of dAcc/dt_Pk, were positively correlated with dAcc/dt_Pk. The interval between EMG onset and EMG peak decreased with increasing dAcc/dt_Pk. The duration of the initial negative phase in the EMGs, which was considered to index the time required to recruit high-threshold MUs, decreased with increasing dAcc/dt_Pk. The results indicate that the ability to rapidly accelerate the lower arm varies across subjects, probably due in part to individual differences in the neural capacity to drive the agonists.     

Brief Cognitive Behavioral Therapy for Insomnia in Parkinson's Disease: A Case Series Study1

Parkinson's disease (PD) patients frequently suffer from insomnia and insomnia can result in reduction of quality of life in PD. Although pharmacotherapy is most applicable for insomnia, it may cause side-effects in PD. The purpose of the study was to investigate the efficacy of brief cognitive behavioral therapy for insomnia (CBTI) in PD. A total of 11 PD patients aged 43–84 years with chronic insomnia received two sessions of CBTI. Patients reported a significant decrease in total score for the Insomnia Severity Index (ISI). The total score for the Parkinson's Disease Sleep Scale (PDSS) improved. Although objective sleep measured by actigraph did not improve, subjective sleep measured by sleep diary improved. Functional impairment measured by the Sheehan Disability Scale (SDS) significantly decreased. These results revealed that brief CBTI was effective in improving insomnia in PD, with improvements extending to functional impairments that had been affected by insomnia. Additionally, this non-pharmacotherapy treatment could be easily applied to PD patients who may have difficulty coming to the clinic frequently due to physical symptoms.